Results 101 to 110 of about 4,045,135 (314)

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

open access: yesMolecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault   +12 more
wiley   +1 more source

Machine learning-based radiopathomics ensemble model for predicting multiple molecular subtypes of adult diffuse glioma: a multicenter retrospective study

open access: yesBMC Cancer
Background IDH and TERTp mutations serve as key molecular markers in glioma, closely associated with tumor clinical behavior, treatment response, and patient survival.
Xuan Li   +5 more
doaj   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients [PDF]

open access: yes, 2013
Molecular subtyping of breast cancer may provide additional prognostic information regarding patient outcome. However, its clinical significance remains to be established.
Bofin, Anna M.   +16 more
core   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Correlation between various perfusion parameters and molecular markers and subtypes.

open access: yes, 2016
Correlation between various perfusion parameters and molecular markers and subtypes.
Hyun-Bin Kim (3609215)   +7 more
core   +1 more source

Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer

open access: yes, 2022
The anticancer effects of ruxolitinib and calcitriol against breast cancer were reported previously. However, the effect of ruxolitinib and calcitriol combination treatment on various molecular subtypes of breast cancer remains unexplored. In this study,
Seung Taek Lim   +3 more
core   +1 more source

Nonfamilial breast cancer subtypes

open access: yes, 2013
Over the last decade, our knowledge in somatic genetic events related to breast cancer has increased -enormously. Through usage of various genome-wide molecular approaches, it has become increasingly clear that breast cancer is a vastly heterogeneous ...
Ringnér, Markus,   +3 more
core   +2 more sources

Advances in the molecular subtyping of gastric cancer

open access: yesWorld Journal of Surgical Oncology
Despite decades of significant progress in gastric cancer research, the prognosis remains poor because of the disease's high aggressiveness. Historically, gastric cancers were classified based on histopathology and anatomical site-criteria that inadequately support precision therapy.
Chen, Jiayi, Zhang, Xijie, Zhao, Yuzhou
openaire   +2 more sources

Home - About - Disclaimer - Privacy